Project Grant R01EB037592

Award Date 8/1/25
Completion Date 7/31/29
Dollars Obligated $496K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This $384,863 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program supports research to develop a novel radiotracer imaging agent for detecting Gram-positive bacterial infections associated with implanted medical devices. The key products and services to be delivered include: In vitro testing of a bivalent radiotracer agent...
This $295,308 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will support the development and validation of a novel class of scanning probe microscopy (SPM) probes for rapid identification of infectious disease agents. The awardee, Actoprobe LLC, aims to dramatically improve the sensitivity and spatial resolution of scanning...
This $821,426 Project Grant, awarded on January 16, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health, is funding research to develop nanostructures that selectively target bacteria and create computational models to predict their activity and behavior. The key objectives are to: Use computer-guided design to create and test antimicrobial nanostructures against...
This Project Grant award, totaling $623,622, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The goal is to develop a novel Probe-based Light Sheet Microscopy (PLSM) device and evaluate its clinical utility for in vivo imaging to aid anal cancer screening. The project, which runs from January 2025 to December 2028, involves a...
This $625,909 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research and development of a hydrogel platform technology for delivering topical bacteriophage therapy to treat antibiotic-resistant wound infections. The award aims to develop innovative methods for sustained local delivery of bacteriophages - viruses that kill...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $398,342 to the University of California, Davis to develop a novel miniature two-photon microscope that can simultaneously perform calcium imaging and optogenetic manipulation of neural activity in freely behaving mice. The device will integrate advanced optical and...
The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Ironsides Medical Inc. provides $275,000 to develop a novel AI-powered otoscope for diagnosing ear infections. The project aims to improve diagnostic accuracy from 50-60% to over 92% by automating the otoscope procedure and utilizing advanced adaptive algorithms to analyze digitally acquired images. This is expected to reduce the long-term health consequences of improper...
This federal Project Grant award of $713,170.00 from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA program 93.173 "Research Related to Deafness and Communication Disorders" aims to develop a multimodality micro-optical coherence tomography (MM-MOCT) imaging technology for visualizing the functional microanatomy of the human cochlea. The project, titled "Multimodality Micro-Optical Coherence Tomography for Imaging the Functional...
Pionear Technologies Inc. received a $699,002 Project Grant award from the National Institute on Deafness and Other Communication Disorders within the Department of Health and Human Services. The award is part of the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) to develop novel liquid-infused tympanostomy tubes with optimized lumen geometry and slippery material design. The goal of the project is to engineer tympanostomy tubes that more efficiently...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will support the development of chemical probes to enable imaging and phototherapeutic treatment of otitis media (OM), a common middle ear infection primarily affecting children. The $496,496 award to The Leland Stanford Junior University will fund research focused on three primary aims: 1) developing a covalent probe targeting bacterial D,D-carboxypeptidases to specifically detect OM-causing bacteria, 2) demonstrating the probe's ability to both image and kill the five most common OM-causing bacteria in vitro, and 3) validating the probe's effectiveness for imaging and clearing these bacteria in a mouse model of OM. This innovative approach seeks to provide a new diagnostic and treatment strategy for OM that can reduce antibiotic overuse and the growing threat of antimicrobial resistance.

Generated 8/5/25, 6:11 AM